Donor-specific antibody detection: comparison of single antigen assay and Luminex crossmatches

被引:10
作者
Caro-Oleas, J. L. [1 ]
Gonzalez-Escribano, M. F. [1 ]
Toro-Llamas, S. [1 ]
Acevedo, M. J. [1 ]
Martinez-Bravo, M. J. [1 ]
Aguilera, I. [1 ]
Nunez-Roldan, A. [1 ]
机构
[1] Univ Seville, Hosp Univ Virgen de Rocio, Serv Inmunol, Edificio Labs,Inst Biomed IBIS, Seville 41013, Spain
来源
TISSUE ANTIGENS | 2010年 / 76卷 / 05期
关键词
donor-specific antibodies; HLA antibodies; Luminex crossmatches; sensitivity; single antigen assay; TRANSPLANT PATIENTS; HLA ANTIBODY; BEADS; LYMPHOCYTOTOXICITY; IDENTIFICATION;
D O I
10.1111/j.1399-0039.2010.01531.x
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Luminex bead-based assays are routinely used in the study of anti-human leukocyte antigen (HLA) donor-specific antibodies (DSA). Single antigen (SA) assays use beads coated with recombinant antigens whereas Luminex crossmatch (Xm-DSA) tests consist of beads coated with isolated donor-specific HLA molecules. The aim of this study was to compare these techniques used to detect DSA. A total of 24 sera recognizing different HLA class I (seven anti-HLA-A and seven anti-HLA-B) as well as class II (seven anti-HLA-DR and three anti-HLA DQ) specificities by complement dependent cytotoxicity were included in the study. These sera were used undiluted and in serial dilutions to perform both class I and II SA and Xm-DSA assays. In the case of Xm-DSA the same serum was checked with different lysates. A total of 42 lysates were used to perform a total of 61 crossmatches: 42 to detect anti-class I and 19 to detect anti-class II antibodies. The maximum positive dilution was higher for SA in 76% of the class I and in 90% of the class II crossmatches. Those cases with a higher sensitivity of the Xm-DSA could not be explained by a larger number of antigen targets.
引用
收藏
页码:398 / 403
页数:6
相关论文
共 19 条
[1]
Luminex donor-specific crossmatches [J].
Billen, E. V. A. ;
Voorter, C. E. M. ;
Christiaans, M. H. L. ;
van den Berg-Loonen, E. M. .
TISSUE ANTIGENS, 2008, 71 (06) :507-513
[2]
No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients [J].
Christiaans, MHL ;
Overhof, R ;
tenHaaft, A ;
Nieman, F ;
vanHooff, JP ;
vandenBergLoonen, EM .
TRANSPLANTATION, 1996, 62 (09) :1341-1347
[3]
Transplanting the sensitized patient [J].
Crew, R. John ;
Ratner, Lloyd E. .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2007, 12 (04) :415-419
[4]
Duquesnoy RJ, 2003, ARCH PATHOL LAB MED, V127, P149
[5]
Solid phase testing in the HLA laboratory: implications for organ allocation [J].
Eckels, D. D. .
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2008, 35 (4-5) :265-274
[6]
HLA antibody identification with single antigen beads compared to conventional methods [J].
El-Awar, N ;
Lee, J ;
Terasaki, PI .
HUMAN IMMUNOLOGY, 2005, 66 (09) :989-997
[7]
CROSS-MATCH PROCEDURES USED IN ORGAN-TRANSPLANTATION [J].
GEBEL, HM ;
LEBECK, LK .
CLINICS IN LABORATORY MEDICINE, 1991, 11 (03) :603-620
[8]
Conundrums with FlowPRA™ beads [J].
Gebel, HM ;
Harris, SB ;
Zibari, G ;
Bray, RA .
CLINICAL TRANSPLANTATION, 2002, 16 :24-29
[9]
Grigsby SJ, 2005, HUM IMMUNOL, V66, pS88
[10]
Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant? [J].
Gupta, Arun ;
Iveson, Victoria ;
Varagunam, Mira ;
Bodger, Stephen ;
Sinnott, Paul ;
Thuraisingham, Raj C. .
TRANSPLANTATION, 2008, 85 (08) :1200-1204